1,067 results
Search Results
2. Call for Special Issue Papers.
- Subjects
- *
SUBSTANCE abuse treatment , *WORKING papers , *MANUSCRIPTS , *EDITORS , *SCHOLARLY peer review - Abstract
The article focuses on invitation for the submission of special issue concept papers which focuses on identification and treatment of substance abuse. Topics discussed include concept papers must have clear topics and tie proposed manuscripts, concept paper submitted must have a lead author who will function as guest editor, special issue will have manuscripts on unpublished research, it must be submitted through online submission system and will undergo peer review process.
- Published
- 2016
- Full Text
- View/download PDF
3. ASAM elaborates on its buprenorphine dosing paper.
- Author
-
Knopf, Alison
- Subjects
- *
METHADONE treatment programs , *TREATMENT programs , *SUBSTANCE abuse , *SUBSTANCE abuse treatment , *BUPRENORPHINE , *MEDICAL protocols , *METHADONE hydrochloride , *ADULT education workshops - Abstract
Last week, ADAW featured a published paper recommending that higher doses of buprenorphine be used in the era of fentanyl (see "ASAM recommends higher doses if needed for treatment with buprenorphine," ADAW, Jan. 7, 2024, https://onlinelibrary.wiley.com/doi/full/10.1002/adaw.33984). The American Society of Addiction Medicine (ASAM) did not have time to get back to us by deadline but did respond to our questions for this week's issue. Below are our questions, in italics, followed by their responses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Involvement of people who use alcohol and other drug services in the development of patient‐reported measures of experience: A scoping review.
- Author
-
van der Sterren, Anke E., Nathan, Sally, Rawstorne, Patrick, Yarbakhsh, Elisabeth, Gough, Chris, and Bowles, Devin
- Subjects
ONLINE information services ,CINAHL database ,TREATMENT programs ,MEDICAL information storage & retrieval systems ,SUBSTANCE abuse treatment ,SYSTEMATIC reviews ,PRIVATE sector ,SATISFACTION ,HEALTH outcome assessment ,HARM reduction ,REHABILITATION of people with alcoholism ,RESEARCH funding ,LITERATURE reviews ,MEDLINE - Abstract
Introduction: Patient‐reported measures that assess satisfaction and experience are increasingly utilised in healthcare sectors, including the alcohol and other drug (AOD) sector. This scoping review identifies how and to what extent people accessing AOD services have been involved in the development of satisfaction and experience measures to date. Methods: PubMed, EMBASE, CINAHL, Scopus, ProQuest, Google and Google Scholar were searched. Included papers described the development and/or implementation of a multiple‐item measure of patient‐reported experience or satisfaction specifically for people accessing AOD treatment and/or harm reduction programmes. If there was more than one paper, key papers were chosen that described each measure. The method of development, including service user involvement, was assessed against a framework generated for this review. Two reviewers were involved at each stage. Results: Thirty measures—23 satisfaction and 7 experience—were identified. Sixteen measures reported some level of involvement by people accessing AOD services in their development, although, for most measures, at a relatively low level. This involvement increased over the time span of the review becoming more frequent in later years. Only four measures were developed for use in harm reduction‐specific settings, and fewer than half reported undertaking analysis of underlying scale structure and constructs. Conclusion: Several gaps could be addressed to enhance the measurement of patient‐centred care in the AOD sector, including: developing experience measures for use in harm reduction settings and across various AOD settings in a service system; improved reporting of psychometric properties of these measures and increasing commitment to the meaningful involvement of AOD service users in measure development. Patient or Public Contribution: This scoping review is part of a broader codesign project that involves a partnership between the peak organisation for AOD services and the peer‐based AOD consumer organisation in the Australian Capital Territory, Australia. These organisations are working closely together to engage with AOD service users, service providers and policy makers in this codesign project. As such, the Executive Director of the peer‐based AOD consumer organisation is involved as a co‐author of this scoping review. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Call for Special Issue Papers.
- Subjects
- *
SUBSTANCE abuse treatment , *PSYCHIATRY - Abstract
A call for papers on the etiology, prevention, identification and treatment of substance abuse for the "American Journal on Addictions," is presented.
- Published
- 2018
- Full Text
- View/download PDF
6. Call for Review Papers.
- Subjects
- *
SUBSTANCE abuse treatment , *PSYCHIATRY - Abstract
A call for papers on the etiology, prevention, identification and treatment of substance abuse for the "American Journal on Addictions," is presented.
- Published
- 2018
- Full Text
- View/download PDF
7. AATOD paper confronts methadone controversies.
- Author
-
Knopf, Alison
- Subjects
HEALTH policy ,METHADONE hydrochloride ,PUBLIC health ,SUBSTANCE abuse treatment ,TREATMENT programs - Abstract
A policy paper released this month by the American Association for the Treatment of Opioid Dependence (AATOD) focuses on some of the challenges facing opioid treatment programs (OTPs) today. For example, it cites an article published in the New England Journal of Medicine (July 5, 2018) by Michael Botticelli that promotes the idea of methadone being available in primary practice settings for the treatment of opioid use disorder (OUD) (see ADAW, July 16, 2018). "AATOD recommends that this proposal should only be considered after careful, conservative, and thoughtful evaluation," according to the policy paper. "As history and our policies have shown, we do not reject the public health model for increasing access to care for OUD, nor are we ignoring what has been learned about clinical standards of care to treat this illness. It is important to understand, however, the complexity of inducting a new patient into methadone maintenance treatment when developing policies for increasing access to medication assisted treatment." [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
8. Prominent researchers argue against more of the same in treatment funding.
- Author
-
Enos, Gary
- Subjects
CONFLICT (Psychology) ,HEALTH services accessibility ,MEDICAL quality control ,HEALTH policy ,NARCOTICS ,PRACTICAL politics ,SUBSTANCE abuse treatment ,GOVERNMENT aid ,HEALTH insurance reimbursement ,TREATMENT programs - Abstract
An over‐reliance on federal block grants and "one‐off" funding initiatives has left the addiction treatment system under‐resourced to respond to an addiction crisis that stands to be at least as deadly as COVID‐19 during the span of the Biden administration, a trio of prominent researchers argue in a newly released policy paper. The authors suggest that the new administration and Congress should prioritize efforts to build on what they consider the most impactful developments in improving access and quality in addiction treatment, such as Medicaid expansion and parity mandates. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. An international systematic review of smoking prevalence in addiction treatment.
- Author
-
Guydish, Joseph, Passalacqua, Emma, Pagano, Anna, Martínez, Cristina, Le, Thao, Chun, JongSerl, Tajima, Barbara, Docto, Lindsay, Garina, Daria, and Delucchi, Kevin
- Subjects
SUBSTANCE abuse treatment ,SMOKING statistics ,TOBACCO use ,PEOPLE with drug addiction ,HISTORY - Abstract
Aims Smoking prevalence is higher among people enrolled in addiction treatment compared with the general population, and very high rates of smoking are associated with opiate drug use and receipt of opiate replacement therapy (ORT). We assessed whether these findings are observed internationally. Methods PubMed, PsycINFO and the Alcohol and Alcohol Problems Science Database were searched for papers reporting smoking prevalence among addiction treatment samples, published in English, from 1987 to 2013. Search terms included tobacco use, cessation and substance use disorders using and/or Boolean connectors. For 4549 papers identified, abstracts were reviewed by multiple raters; 239 abstracts met inclusion criteria and these full papers were reviewed for exclusion. Fifty-four studies, collectively comprising 37 364 participants, were included. For each paper we extracted country, author, year, sample size and gender, treatment modality, primary drug treated and smoking prevalence. Results The random-effect pooled estimate of smoking across people in addiction treatment was 84% [confidence interval (CI) = 79, 88%], while the pooled estimate of smoking prevalence across matched population samples was 31% (CI = 29, 33%). The difference in the pooled estimates was 52% (CI = 48%, 57%, P < .0001). Smoking rates were higher in programs treating opiate use compared with alcohol use [odds ratio (OR) = 2.52, CI = 2.00, 3.17], and higher in ORT compared to out-patient programs (OR = 1.42, CI = 1.19, 1.68). Conclusions Smoking rates among people in addiction treatment are more than double those of people with similar demographic characteristics. Smoking rates are also higher in people being treated for opiate dependence compared with people being treated for alcohol use disorder. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
10. Call for Special Issue Papers.
- Subjects
- *
SUBSTANCE abuse treatment , *DRUG abuse - Abstract
The article reports on the call of the organization American Academy of Addiction Psychiatry (AAAP) for concept articles that focused on the treatment of substance abuse, ontogenetics, and addictive disorders.
- Published
- 2016
- Full Text
- View/download PDF
11. Call for Review Papers.
- Subjects
- *
SUBSTANCE abuse treatment , *DRUG abuse , *PSYCHIATRY - Abstract
The article reports on the call of the journal for review articles that focused on etiology and treatment of substance abuse, and addiction psychiatry.
- Published
- 2016
- Full Text
- View/download PDF
12. AATOD white paper details how OTPs and buprenorphine providers can collaborate.
- Subjects
- *
BUPRENORPHINE , *DRUG addiction , *INTERPROFESSIONAL relations , *NARCOTICS , *PHYSICIANS , *SUBSTANCE abuse treatment - Abstract
A new report from the American Association for the Treatment of Opioid Dependence (AATOD) focuses on how opioid treatment programs (OTPs) can collaborate with other health care providers, including office-based buprenorphine prescribers, on closing the treatment gap for opioid use disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
13. ‘Incentivizing Recovery’ follow‐up: White paper was a ‘first step’.
- Author
-
Knopf, Alison
- Subjects
MEDICAL ethics ,PRIVACY ,SUBSTANCE abuse treatment ,HEALTH insurance reimbursement ,TREATMENT programs - Abstract
Last week's issue featured the announcement of a new payment model for addiction treatment, a combination of capitated and bundled reimbursement that places the treatment provider at risk in the event of repeat admissions. Greg Williams, executive vice president of Facing Addiction with NCADD, described the rationale for the system: Treatment providers should not be paid if patients don't get well. Anne Marie Polak, senior director at Leavitt Partners and in charge of the “Incentivizing Recovery” project the organization is convening, described the basics of how the project works. None of the treatment organizations participated in the project, which resulted in the white paper released Sept. 7 (see ADAW, Sept. 17). [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
14. Drug consumption rooms: A systematic review of evaluation methodologies.
- Author
-
Belackova, Vendula, Salmon, Allison M., Day, Carolyn A., Ritter, Alison, Shanahan, Marian, Hedrich, Dagmar, Kerr, Thomas, and Jauncey, Marianne
- Subjects
DRUG utilization ,EVALUATION methodology ,META-analysis ,OPERATIONS research ,BLOODBORNE infections ,INTRAVENOUS drug abuse ,DRUG overdose ,NEEDLE exchange programs ,SUBSTANCE abuse treatment ,SYSTEMATIC reviews ,TREATMENT programs ,EVALUATION research ,HARM reduction - Abstract
Issues: Drug consumptions rooms (DCR) and supervised injecting facilities (SIF) are expanding internationally. Previous reviews have not systematically addressed evaluation methodologies.Approach: Results from systematic searches of scientific databases in English until June 2017 were coded for paper type, country and year of publication. For evaluation papers, study outcome, methodology/study design and main indicators of DCR/SIF 'exposure' were recorded.Key Findings: Two hundred and nineteen eligible peer-reviewed papers were published since 1999: the majority from Canada (n = 117 papers), Europe (n = 36) and Australia (n = 32). Fifty-six papers reported evaluation outcomes. Ecological study designs (n = 10) were used to assess the impact on overdose, public nuisance and crime; modelling techniques (n = 6) estimated impact on blood-borne diseases, overdose deaths and costs. Papers using individual-level data included four prospective cohorts (n = 28), cross-sectional surveys (n = 7) and service records (n = 5). Individual-level data were used to assess safer injecting practice, uptake into health and social services and all the other above outcomes except for impact on crime and costs. Four different indicators of DCR/SIF attendance were used to measure service 'exposure'.Implications: Research around DCRs/SIFs has used ecological, modelling, cross-sectional and cohort study designs. Further research could involve systematic inclusion of a control group of people who are eligible but do not access SIFs, validation of self-reported proportion of injections at SIFs or a stepped-wedge or a cluster trial comparing localities.Conclusions: Methodologies appropriate for DCR/SIF evaluation have been established and can be readily replicated from the existing literature. Research on operational aspects, implementation and transferability is also warranted. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
15. Integrating smoking cessation care in alcohol and other drug treatment settings using an organizational change intervention: a systematic review.
- Author
-
Skelton, Eliza, Tzelepis, Flora, Shakeshaft, Anthony, Guillaumier, Ashleigh, McCrabb, Sam, and Bonevski, Billie
- Subjects
CIGARETTE smokers ,ALCOHOLISM ,PEOPLE with alcoholism ,SMOKING ,ALCOHOLISM treatment ,SUBSTANCE abuse treatment ,CINAHL database ,HOSPITAL medical staff ,MEDICAL information storage & retrieval systems ,PSYCHOLOGY information storage & retrieval systems ,INTEGRATED health care delivery ,MEDLINE ,ORGANIZATIONAL change ,QUALITY assurance ,SMOKING cessation ,STRATEGIC planning ,SYSTEMATIC reviews ,TOBACCO products ,DISCHARGE planning ,TREATMENT effectiveness ,DISEASE prevalence - Abstract
Background and Aims: Organizational change interventions involve systems and cultural change within health‐care services to make smoking cessation care delivery part of usual treatment. Six strategies for organizational change have been proposed. This study examined the evidence for organizational change interventions in the alcohol and other drug (AOD) setting on: (a) smoking cessation care; and (b) smoking cessation and cessation‐related outcomes. Methods: A systematic review with narrative synthesis was conducted. MEDLINE, PsycINFO, CINAHL, EMBASE and Scopus were searched using keywords and MeSH terms from database inception to 1 June 2018. Interventions were assessed against the six organizational change strategies. Results: Of the 5155 papers identified, 14 publications from seven unique studies were included. Most studies employed four or fewer organizational change strategies. The majority (n = 11) were rated weak to moderate in methodological quality. Nine published papers, four unique studies, examined staff reported provision of smoking cessation care; eight reported an increase, one found no change. Three papers, two unique studies, examined client receipt of care; all found significant increases. Three papers, two unique studies, assessed staff smoking prevalence from pre‐ to post‐intervention. Only one study reported a significant reduction in staff smoking prevalence (35.2 versus 21.8%, P = 0.005). Nine papers, six unique studies, assessed client smoking cessation and smoking‐related outcomes. Seven papers reported on client smoking prevalence; two found a significant decrease and five found no change to smoking. Four papers reported on number of cigarettes per day, three found a significant decrease and one found no change. Two papers reported on smoking cessation finding a 10% and a 25% seven‐day point prevalence abstinence post‐discharge from the AOD service. Conclusions: Organizational change interventions within health‐care services to make smoking cessation care delivery part of usual treatment offer promise for increasing smoking cessation care and reducing smoking prevalence. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
16. Call for Review Papers.
- Subjects
SUBSTANCE abuse treatment ,SUBSTANCE abuse prevention ,ADDICTIONS ,PERIODICALS - Abstract
A call for review papers on the etiology, prevention, identification and treatment of substance abuse for the Special Issue series of the "American Journal on Addictions" is presented.
- Published
- 2017
- Full Text
- View/download PDF
17. Call for Special Issue Papers.
- Subjects
SUBSTANCE abuse treatment ,SUBSTANCE abuse prevention ,ADDICTIONS ,PERIODICALS - Abstract
A call for papers on the etiology, prevention, identification and treatment of substance abuse for the Special Issue series of the "American Journal on Addictions" is presented.
- Published
- 2017
- Full Text
- View/download PDF
18. Call for Review Articles.
- Subjects
- *
CONFERENCE papers , *SUBSTANCE abuse prevention , *SUBSTANCE abuse treatment - Abstract
The article invites submission for review articles focused on the etiology, prevention, identification, and treatment of substance abuse.
- Published
- 2017
- Full Text
- View/download PDF
19. Treating equivalent cases differently: A comparative analysis of substance use disorder and type 2 diabetes in Norwegian treatment guidelines.
- Author
-
Moe, Fredrik D. and Berg, Henrik
- Subjects
SUBSTANCE abuse treatment ,CHRONIC disease treatment ,HEALTH policy ,WORLD health ,TYPE 2 diabetes ,MEDICAL protocols ,COMPARATIVE studies ,CONTINUUM of care ,PATIENT care ,POLICY sciences - Abstract
Background: Substance use disorder (SUD) is often understood as a chronic illness. Aims: This paper investigates whether SUD is treated as a chronic illness. Method: To this aim, we have used World Health Organizations (WHO's) definition of chronic illness to conduct a comparative analysis of SUD and type 2 diabetes (T2D), which is another chronic illness. Results: When analysing Norwegian treatment guidelines, we found that only the T2D guideline reflects the WHO's conceptualization of chronic illnesses. We argue that this discrepancy implies that SUD is understood as a moral and legal problem, while T2D is conceptualized as a somatic illness. We discuss how social, political and historical conditions of the possibility for understanding SUD are interwoven with normative presumptions about the clinician, patient, treatment guidelines and drug policies in a way that may impede the development of continuing care. Conclusion: The paper concludes that the delivery of treatment services is inequitable as SUD is not treated as a chronic illness. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Beacon calls for primary care and MAT to expand opioid treatment access.
- Author
-
Knopf, Alison
- Subjects
BUPRENORPHINE ,CHRONIC diseases ,CONTINUUM of care ,HEALTH services accessibility ,INSURANCE companies ,MANAGED care programs ,MEDICAL care ,NARCOTICS ,PRIMARY health care ,SUBSTANCE abuse treatment ,HEALTH insurance reimbursement - Abstract
The article discusses a white paper issued by Beacon Health Options "Confronting the Crisis of Opioid Addication" calling for a focus on outpatient medication-assisted treatment by primary care. Topics discussed include its focus on the need to treat opioid addiction as chronic condition, its criticism of providers of detox who did not participate in the continuum of care needed for chronic conditions and its support for 10 levels of care of the American Society of Addiction Medicine (ASAM).
- Published
- 2015
- Full Text
- View/download PDF
21. The development of a pilot 'thinking about relationships prompt sheet' within an alcohol and other drugs rehabilitation programme.
- Author
-
Anderson, Bella and Furlong, Mark
- Subjects
THOUGHT & thinking ,FRIENDSHIP ,WELL-being ,FAMILY psychotherapy ,TREATMENT programs ,EVALUATION of human services programs ,SUBSTANCE abuse treatment ,CONVALESCENCE ,SOCIAL values ,SELF-evaluation ,HUMAN services programs ,INTERPERSONAL relations ,ALCOHOL drinking ,INTELLECT ,ACTION research ,SOCIAL skills - Abstract
This paper documents the development of a programme component within an alcohol and other drugs residential service. Designed to improve relational competence, this pilot component was designed to have multiple levels of function: from the specific, for example, stimulating residents to formulate and monitor relationally oriented goals, to the more pacific, for example, embedding relationally focused learning as an ongoing rehabilitative concern. Development of the component began with a literature review. After finalising a set of relationship types (friends, siblings, etc.), this review identified three domains: 'values', 'knowledge' and 'skills'. To create an initial draft, these categories were populated by items selected from a multi‐stage inspection of the relevant literature. This draft was then reviewed by multiple stakeholder groups. Feedback from these consultations resulted in substantial modifications to the initial draft. In addition to the component having a broad‐spectrum interventive purpose, the authors propose that this component could play a role in (i) pre‐admission assessment and (ii) programme evaluation insofar as data concerning individual residents are aggregated and analysed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
22. AATOD white paper on how OTPs can work with Bupe providers.
- Author
-
Knopf, Alison
- Subjects
BUPRENORPHINE ,DRUGS ,SUBSTANCE abuse ,SUBSTANCE abuse treatment ,TREATMENT programs - Abstract
The article presents the white paper from American Association for the Treatment of Opioid Dependence (AATOD) which focuses on how opioid treatment programs can coordinate with office-based buprenorphine prescribers.
- Published
- 2016
- Full Text
- View/download PDF
23. Report: 1115 waivers provide funds but don't ensure effective SUD care.
- Author
-
Enos, Gary
- Subjects
MEDICAID law ,SUBSTANCE abuse treatment ,SUBSTANCE abuse ,MEDICAL quality control ,NARCOTICS ,HEALTH services accessibility ,REPORT writing ,ANALGESICS ,HEALTH insurance reimbursement ,QUALITY assurance ,GOVERNMENT aid ,MEDICAL needs assessment - Abstract
The primary manner by which states have been using Medicaid to expand access to substance use disorder (SUD) treatment may actually be making it more difficult for individuals to receive the services most appropriate to their needs, a newly released paper suggests. Moreover, this preferred strategy in many cases violates the law, authors with the National Health Law Program contend. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. Mentalization‐based treatment and its evidence‐base status: A systematic literature review.
- Author
-
Malda‐Castillo, Javier, Browne, Claire, and Perez‐Algorta, Guillermo
- Subjects
SUBSTANCE abuse treatment ,TREATMENT of borderline personality disorder ,SYSTEMATIC reviews ,EVIDENCE-based medicine ,RESEARCH bias ,PSYCHOTHERAPY ,SELF-mutilation ,ADOLESCENCE - Abstract
Purpose: This study reviewed the evidence‐base status of mentalization‐based treatment (MBT), its quality, strengths, and limitations. The aim was to pave the way for further MBT research. Method: An electronic database and reference lists search identified MBT outcome papers, and these were systematically reviewed. The quality of the studies and the risk of bias were determined using two validated checklist tools. Results: Twenty‐three studies were included in the review. This included nine randomized controlled trials, seven uncontrolled pre‐ and post‐effectiveness studies, three retrospective cohort studies, two uncontrolled randomized trials, and two case studies. The methodological quality of almost half of the papers was assessed as fair (43%), followed by good (34%), poor (17%), and excellent (4%) ratings. Nevertheless, the review identified risk of confounding bias across the majority of studies (60%) and fidelity to treatment was poorly reported in almost half of the studies (47%). Most of the studies focused on borderline personality disorder (BPD), showing positive clinical outcomes for this population but the evidence‐base for other presentations was still developing. The treatment of adolescents who self‐harm and at‐risk mothers in substance abuse treatment showed particularly promising results, as these are client groups that have previously shown limited positive response to psychological interventions. Conclusions: Mentalization‐based treatment is a potentially effective method across a wide range of clinical presentations but further research should focus on increasing the quality and the quantity of the MBT evidence outside the treatment of BPD. Practitioner points: MBT can be a particularly effective intervention for the treatment of adults with a diagnosis of BPD and of adolescents who self‐harm and mothers enrolled in substance abuse treatments.MBT can be an effective intervention for depression and eating disorders but the evidence is currently limited.Professionals supporting mothers of children at risk may benefit from receiving training in the principles of MBT. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
25. Civil commitment for SUDs: One answer for families?
- Subjects
SUBSTANCE abuse treatment ,INVOLUNTARY hospitalization -- Law & legislation ,SUBSTANCE abuse ,TREATMENT programs ,RESIDENTIAL care - Abstract
This summer, the Hazelden Betty Ford Foundation released a research paper embracing the concept of civil commitment for substance use disorders (SUDs). The driving force is similar to that for suicidality: saving the life of a possible overdose victim. In issuing this paper, called 'Involuntary Commitment for Substance Use Disorders,' Hazelden Betty Ford has opened a national dialogue among treatment providers on this controversial issue. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
26. Koob: Understanding negative reinforcers of opioids could uncover new treatments.
- Author
-
Enos, Gary
- Subjects
SUBSTANCE abuse treatment ,TREATMENT of drug withdrawal symptoms ,PSYCHOLOGICAL adaptation ,ANALGESICS ,COGNITIVE therapy ,NARCOTICS ,REINFORCEMENT (Psychology) ,PSYCHOLOGICAL stress ,STRESS management ,SUBSTANCE abuse ,DISEASE complications - Abstract
A new research paper on the neurobiology of opioid addiction is replete with complex terms, such as the pivotal "hyperkatifeia" (coined about a decade ago to describe an increase in the intensity of the negative emotional signs of drug withdrawal). But the primary takeaway message from the report's author, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Director George Koob, M.D., is much more accessible and direct. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
27. ASAM paper outlines reasons for banning 'medical marijuana'
- Subjects
MEDICAL marijuana ,SUBSTANCE abuse treatment ,DRUG delivery systems ,SUBSTANCE abuse treatment facilities - Abstract
The article looks at a paper authored by the American Society of Addiction Medicine (ASAM) which calls for the banning of medical marijuana due to the oath of physicians to do no harm to patients. The U.S. Food and Drug Administration's policy on smoking marijuana as a means of drug delivery is reviewed. The ASAM's view on the addictive properties of marijuana are discussed.
- Published
- 2011
28. The mental health and substance use treatment experiences of racially and ethnically minoritised women who have experienced sexual violence.
- Author
-
Spaducci, Gilda, Oram, Sian, Thiara, Ravi, Robson, Debbie, Peeren, Siofra, Gibbs, Annie, and Trevillion, Kylee
- Subjects
- *
SUBSTANCE abuse treatment , *MENTAL illness treatment , *MEDICAL information storage & retrieval systems , *WOUNDS & injuries , *SEX crimes , *MENTAL health , *MENTAL health services , *RESEARCH funding , *CINAHL database , *PSYCHOLOGY of women , *DESCRIPTIVE statistics , *RACE , *SYSTEMATIC reviews , *MEDLINE , *RACISM , *MINORITIES , *TREATMENT programs , *DATA analysis software , *PATIENTS' attitudes , *PSYCHOLOGY information storage & retrieval systems - Abstract
The mental health and substance use treatment experiences of racially and ethnically minoritised women who have experienced sexual violence is not well understood. To address this we conducted a systematic review and meta‐synthesis of qualitative studies. Our search strategy included electronic searches of 18 databases and grey literature, citation tracking and reference list screening. Studies were eligible if they presented qualitative data from racially and/or ethnically minoritised women or girls, who had experienced sexual violence at any age and described their experiences of receiving treatment from statutory mental health and/or substance use services. Studies were analysed using meta‐ethnography. Fourteen papers based on 12 individual studies were included. Analysis developed three main themes: (1) understanding minoritised women holistically, (2) processing the trauma and beginning the healing and (3) the need for social connectedness and empowering relationships. For minoritised women to benefit from treatment, mental health and substance use services need to challenge the dynamics of the multiple traumas minoritised women experience. Knowledge and understanding of the racial trauma minoritised women experience is limited and many are subjected to further harm from racist practices occurring in some treatment services. Offering culturally safe, trauma‐informed care which promotes anti‐racist practices may help improve mental health and substance use service responses to minoritised women who have experienced sexual violence. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. A critique of the Australian National Health and Medical Research Council CEO statement on electronic cigarettes.
- Author
-
Mendelsohn, Colin P., Hall, Wayne, Borland, Ron, Wodak, Alex, Beaglehole, Robert, Benowitz, Neal L., Britton, John, Bullen, Chris, Etter, Jean‐François, McNeill, Ann, and Rigotti, Nancy A.
- Subjects
SUBSTANCE abuse treatment ,SMOKING prevention ,ELECTRONIC cigarettes ,ATTITUDE (Psychology) ,PUBLIC health ,EXECUTIVES ,NICOTINE ,GOVERNMENT agencies ,SMOKING ,MEDICAL research - Abstract
This paper critically analyses a statement by Australia's National Health and Medical Research Council (NHMRC) on e‐cigarettes in May 2022 that will be used to guide national policy. We reviewed the evidence and the conclusions drawn in the NHMRC Statement. In our view, the Statement is not a balanced reflection of the benefits and risks of vaping because it exaggerates the risks of vaping and fails to compare them to the far greater risks of smoking; it uncritically accepts evidence of harms from e‐cigarettes while adopting a highly sceptical attitude towards evidence of their benefits; it incorrectly claims that the association between adolescent vaping and subsequent smoking is causal; and it understates the evidence of the benefits of e‐cigarettes in assisting smokers to quit. The Statement dismisses the evidence that vaping is probably already having a positive net public health effect and misapplies the precautionary principle. Several sources of evidence supporting our assessment were published after the NHMRC Statement's publication and are also referenced. The NHMRC Statement on e‐cigarettes does not present a balanced assessment of the available scientific literature and fails to meet the standard expected of a leading national scientific body. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. In case you haven't heard...
- Subjects
- *
SUBSTANCE abuse treatment , *PAPER clips , *PHARMACOLOGY - Abstract
The article explains that stainless steel paper clips help in the production of medications that treat addiction because the steel makes chemical reactions produce a higher opiate yield in drugs such as buprenorphine with naloxone.
- Published
- 2011
31. Is there really no evidence of the efficacy of brief alcohol interventions for increasing subsequent utilization of alcohol-related services? Commentary on the paper by Glass et al. (2015).
- Author
-
Simioni, Nicolas, Rolland, Benjamin, and Cottencin, Olivier
- Subjects
SUBSTANCE abuse treatment ,ALCOHOLISM treatment ,MEDICAL referrals ,SYSTEMATIC reviews ,TREATMENT programs ,SEVERITY of illness index - Abstract
A letter to the editor is presented in response to the study "Specialty Substance Use Disorder Services Following Brief Alcohol Intervention: A Meta-Analysis of Randomized Controlled Trials" by J.E. Glass, A.M. Hamilton, B.J. Powell, B.E. Perron, R.T. Brown, and M.A. Ilgen in volume 110 of the periodical.
- Published
- 2016
- Full Text
- View/download PDF
32. Downfall of 'one-stop addiction recovery empire' reported in Florida paper.
- Author
-
Knopf, Alison
- Subjects
MEDICAL economics ,URINALYSIS ,SUBSTANCE abuse treatment ,TREATMENT programs - Abstract
The article focuses on a report in an issue of the "Palm Beach Post" on the downfall of the sale of a portfolio of addiction recovery treatment centers by real estate investor Frank Cid due to alleged kickbacks, patient brokering and fraud. It cites the alleged unethical practices in patient urine testing and billing, move by Cid to sue Florida Association for Recovery Residences (FARR) president John Lehman for defamation and the impression of Lehman over the revenue source of the centers.
- Published
- 2015
- Full Text
- View/download PDF
33. The Emerging Drugs Network of Australia - Victoria Clinical Registry: A state-wide illicit substance surveillance and alert network.
- Author
-
SYRJANEN, Rebekka, SCHUMANN, Jennifer, FITZGERALD, John, GEROSTAMOULOS, Dimitri, ABOUCHEDID, Rachelle, ROTELLA, Joe-Anthony, KNOTT, Jonathan, MAPLESDEN, Jacqueline, HOLLERER, Hans, HANNON, Liam, BOURKE, Elyssia, HODGSON, Sarah E., and GREENE, Shaun L.
- Subjects
SUBSTANCE abuse treatment ,SUBSTANCE abuse prevention ,BLOOD testing ,SALES personnel ,REPORTING of diseases ,MEETINGS ,PUBLIC health ,DRUG use testing ,GOVERNMENT programs ,HUMAN services programs ,DATABASE management ,RESEARCH funding ,PUBLIC hospitals ,HEALTH care teams ,DRUGS of abuse ,HEALTH promotion - Abstract
Objectives: With an increasingly dynamic global illicit drug market, including the emergence of novel psychoactive substances, many jurisdictions have moved to establish toxicosurveillance systems to enable timely detection of harmful substances in the community. This paper describes the methodology for the Emerging Drugs Network of Australia - Victoria (EDNAV) project, a clinical registry focused on the collection of high-quality clinical and analytical data from ED presentations involving illicit drug intoxications. Drug intelligence collected from the project is utilised by local health authorities with the aim to identify patterns of drug use and emerging drugs of concern. Methods: The project involves 10 public hospital EDs in Victoria, Australia. Patients 16 years and over, presenting to a network ED with a suspected illicit drug-related toxicity and a requirement for venepuncture are eligible for inclusion in the study under a waiver of consent. Clinical and demographic parameters are documented by site-based clinicians and comprehensive toxicological analysis is conducted on patient blood samples via specialised forensic services. All data are then deidentified and compiled in a project specific database. Results: Cases are discussed in weekly multidisciplinary team meetings, with a view to identify potentially harmful substances circulating in the community. High-risk signals are escalated to key stakeholders to produce timely and proportionate public health alerts with a focus on harm minimisation. Conclusions: The EDNAV project represents the first centralised system providing near real-time monitoring of community drug use in Victoria and is fundamental in facilitating evidencebased public health intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
34. Overlooked and underestimated? Problematic alcohol use in clients recovering from drug dependence.
- Author
-
Staiger, Petra K., Richardson, Ben, Long, Caroline M., Carr, Victoria, and Marlatt, G. Alan
- Subjects
SUBSTANCE abuse treatment ,ALCOHOLISM ,CINAHL database ,PSYCHOLOGY information storage & retrieval systems ,MEDLINE ,RESEARCH funding ,SYSTEMATIC reviews - Abstract
Aims Despite recognition of the harms related to alcohol misuse and its potential to interfere substantially with sustained recovery from drug dependency, research evaluating drug treatment outcomes has not addressed the issue comprehensively. It has been overlooked possibly because treatment research has been framed according to the primary drug of choice, rather than investigating the interactions between different combinations of drugs and/or alcohol use. This paper reports on a systematic review investigating whether concurrent alcohol use could impede recovery from illicit drug use in two potential ways: first, alcohol could become a substitute addiction and/or secondly, alcohol misuse post-treatment may place an individual at risk for relapse to their primary drug problem. Method A systematic search of four relevant databases was undertaken to identify peer-reviewed, quantitative drug treatment outcome studies that reported alcohol use pre-, post-treatment and follow-up. Results The search revealed 567 papers, of which 13 were assessed as fulfilling the key inclusion criteria.The review indicated inconsistent and therefore inconclusive support for the substitution hypothesis. However, the data revealed consistent support for the hypothesis that alcohol use increases relapse to drug use. Conclusions (i) The potential negative impact of alcohol misuse on drug treatment outcomes remains under-researched and overlooked; (ii) alcohol consumption post-drug treatment may increase the likelihood that an individual will relapse to their primary drug; (ii) existing evidence regarding the substitution hypothesis is inconclusive, although there was an indication that a subgroup of participants will be vulnerable to alcohol becoming the primary addiction instead of drugs. We argue that future drug treatment outcome studies need to include detailed analysis of the influence of alcohol use pre- and post-drug treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
35. Call for Special Issue Papers.
- Subjects
SUBSTANCE abuse treatment ,HEALTH education ,DRUG abuse prevention - Abstract
An introduction is presented in which the editor discusses various reports within the issue on topics including the prevention, identification and treatment of substance abuse.
- Published
- 2015
- Full Text
- View/download PDF
36. Service integration: The perspective of Australian alcohol and other drug (AOD) nurses.
- Author
-
Searby, Adam, Burr, Dianna, James, Russell, and Maude, Phil
- Subjects
SUBSTANCE abuse treatment ,PSYCHIATRIC nursing ,NURSES' attitudes ,TREATMENT programs ,RESEARCH methodology ,INTERVIEWING ,QUALITATIVE research ,INTEGRATED health care delivery ,THEMATIC analysis ,SECONDARY analysis - Abstract
The recently released Victorian Mental Health Royal Commission report has recommended a shift to integrated treatment, defined as treatment for alcohol and substance use disorders and mental ill health occurring in parallel, rather than distinct systems catering to each need. However, little work has sought to determine the perceptions of nurses working in alcohol and other drug (AOD) treatment towards integrating with mental health services. In this study, we explore the perspectives of specialist AOD nurses towards the integration of mental health and AOD treatment services. Secondary analysis of semi‐structured interviews with Australian specialist AOD nurses (n = 46) conducted as part of a wider workforce study in 2019. Data were analysed using thematic analysis and reported using the COREQ guidelines. Of the interviews analysed, six were AOD nurses working in an Australian state that had recently undergone service integration; however, many participants expressed perceptions of service integration. Two key themes are reported in this paper: (i) perceptions of service integration, where AOD nurses participating in our study were concerned that integration would result in the model of care they worked under being replaced by a mental health‐based model that was felt to be highly risk averse, and (ii) experiences of service integration. Concerns about the focus of care as well as the complexity of care differing between the two services demonstrated a contrast in both philosophical approaches to work with consumers and legislative difference in voluntary versus compulsory care provision. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
37. History and its contribution to understanding addiction and society.
- Author
-
Berridge, Virginia
- Subjects
DRUG abuse ,DRUG abuse policy ,SUBSTANCE abuse ,HEALTH policy ,SUBSTANCE abuse treatment ,HISTORY of research ,PRACTICAL politics ,GOVERNMENT policy ,BOOKS ,HISTORY - Abstract
This paper provides a personal memoir of historical work at the Addiction Research Unit, in particular the genesis of the book Opium and the People. This topic had policy significance for US drug policy and a competing US study was funded. The development of the substance use history field is surveyed, and its expansion in recent times through a focused professional association and a critical mass of researchers in the area, covering a wide range of topics. The politics of using history in this area can be problematic. History now sits at the policy table more easily, but there is still a tendency for professionals in the field to use (and misuse) it, rather than calling on the interpretive and challenging approach they would obtain from professional historians. The paper calls for historians and others to move beyond a substance specific focus and to avoid the tendency for 'naive history' implicit in using only digitized industry archives as the sole source. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
38. Prize-based contingency management for the treatment of substance abusers: a meta-analysis.
- Author
-
Benishek, Lois A., Dugosh, Karen L., Kirby, Kim C., Matejkowski, Jason, Clements, Nicolle T., Seymour, Brittany L., and Festinger, David S.
- Subjects
SUBSTANCE abuse treatment ,AWARDS ,CONFIDENCE intervals ,META-analysis ,MOTIVATION (Psychology) ,RESEARCH funding ,REWARD (Psychology) ,U-statistics ,TREATMENT programs ,RANDOMIZED controlled trials ,BEHAVIOR modification ,PUBLICATION bias ,DATA analysis software ,DESCRIPTIVE statistics ,ODDS ratio - Abstract
Aim To review randomized controlled trials to assess efficacy of a prize-based contingency management procedure in reducing substance use (where a drug-free breath or urine sample provides a chance of winning a prize). Methods A meta-analysis was conducted on papers published from January 2000 to February 2013 to determine the effect size of studies comparing prize-based contingency management to a treatment-as-usual control condition (k = 19 studies). Parallel analyses evaluated the efficacy of both short- (k = nine studies) and long-term outcomes (k = six studies) of prize-based contingency management. Results The average end-of-treatment effect size (Cohen’s d) was 0.46 [95% confidence interval (CI) = 0.37, 0.54]. This effect size decreased at the short-term (≤3-month) post-intervention follow-up to 0.33 (95% CI = 0.12, 0.54) and at the 6-month follow-up time-point there was no detectable effect [d = −0.09 (95% CI = −0.28, 0.10)]. Conclusion Adding prize-based contingency management to behavioral support for substance use disorders can increase short-term abstinence, but the effect does not appear to persist to 6 months. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
39. The narcotic clinic in New Orleans, 1919-21.
- Author
-
Tallaksen, Amund
- Subjects
HISTORY of New Orleans (La.) ,SUBSTANCE abuse treatment facilities ,LOUISIANA governors ,PEOPLE with drug addiction ,PHYSICIANS ,TREATMENT of drug addiction ,HISTORY ,TWENTIETH century ,TREATMENT programs ,SUBSTANCE abuse treatment ,PUBLIC opinion ,QUALITATIVE research ,TREATMENT effectiveness - Abstract
Aims This paper traces the history of the narcotic clinic in New Orleans, Louisiana, comparing its merits to a similar clinic in Shreveport. How do the clinics compare, and why did the Shreveport clinic operate for longer than its New Orleans counterpart? Methods Qualitative analysis of contemporary medical journals and newspapers, as well as archival materials from the Narcotic Division. In addition, the records of Louisiana Governor John M. Parker, the papers of Dr Willis P. Butler in Shreveport, as well as the records of the Orleans Parish Medical Society have been utilized. Findings The narcotic clinic in Shreveport benefited from strong local support, while the New Orleans clinic faced a more vocal opposition. In addition, the Shreveport clinic offered a broad array of services and was a pillar of the community; the New Orleans clinic was newly established and offered fewer services. It was especially the influx of out-of-state addicts that angered many New Orleanians, many of whom witnessed the addicts lined up in the French Quarter. Conclusion The effectiveness of the narcotic clinics in Louisiana (1919-23) was influenced by local opinion. The New Orleans clinic faced a tougher political climate than its counterpart in Shreveport, and therefore proved less resilient in the face of federal opposition. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
40. Screening, Brief Intervention and Referral to Treatment (SBIRT): rationale, program overview and cross-site evaluation.
- Author
-
Bray, Jeremy W., Del Boca, Frances K., McRee, Bonnie G., Hayashi, Susan W., and Babor, Thomas F.
- Subjects
EVALUATION of medical care ,MEDICAL economics ,SUBSTANCE abuse treatment ,SUBSTANCE abuse diagnosis ,CONTINUUM of care ,ENDOWMENTS ,MANAGEMENT ,MEDICAL personnel ,MEDICAL referrals ,MEDICAL screening ,PATIENTS ,RESEARCH funding ,EARLY medical intervention ,TREATMENT duration ,EVALUATION of human services programs ,DESCRIPTIVE statistics - Abstract
Aims Since 2003, the US Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment (SAMHSA, CSAT) has awarded 32 Screening, Brief Intervention and Referral to Treatment (SBIRT) grants to states, territories and tribal organizations to enhance services for persons with, or at risk for, substance use disorders. The grants supported an expansion of the continuum of care to include screening, brief intervention, brief treatment and referral to treatment in general medical and community settings. This paper describes the SAMHSA SBIRT program in the context of the scientific research that motivated its development, as well as the two cross-site evaluations that are the subject of subsequent papers in this Supplement. Methods A narrative review of research evidence pertaining to SBIRT and of the cross-site evaluation design that made it possible to determine whether the SAMHSA SBIRT grant program achieved its intended aims. The 11 programs within the two cohorts of grant recipients that were the subject of the cross-site evaluations are described in terms of SBIRT service components, performance sites, providers, management structure/activities and patient/client characteristics. Conclusion The US SAMHSA SBIRT program is an effective way to introduce a variety of new services that extend the continuum of care for substance-involved individuals, ranging from early intervention with non-dependent substance users to referral of more serious cases to specialized substance abuse treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
41. For veterans with comorbid disorders, more care may mean it's less adequate.
- Author
-
Enos, Gary
- Subjects
SUBSTANCE abuse treatment ,ANTIDEPRESSANTS ,MENTAL depression ,HEALTH services accessibility ,MEDICAL quality control ,MEDICAL protocols ,PSYCHOTHERAPY ,QUALITY assurance ,PSYCHOLOGY of veterans ,COMORBIDITY ,PSYCHIATRIC treatment - Abstract
Two recent research papers highlight ongoing deficiencies in the provision of addiction and mental health treatment services to veterans, though the report focusing on depression treatment for patients with substance use disorders (SUDs) suggests that shortcomings in treatment for co‐occurring disorders affect all populations. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
42. Moving from research to practice just in time: the treatment of cannabis use disorders comes of age.
- Author
-
Westley Clark, H., MacNeill Horton, Arthur, Dennis, Michael, and Babor, Thomas F.
- Subjects
MARIJUANA abuse ,FIELD research - Abstract
This supplement issue on the treatment of marijuana use disorders describes two large multi-site field experiments: the Cannabis Youth Treatment (CYT) study with adolescents and the Marijuana Treatment Project (MTP) with adults. The papers cover multiple aspects of the treatment of cannabis users. including the rationale for studying cannabis use disorders, descriptions of the CYT and MTP studies, characteristics of adolescents and adults presenting for treatment of cannabis use disorders, court diversion issues, economic evaluation and confirmation of self-reported cannabis use, among other topics, This Introduction provides background information and an overview of the papers from the perspective of the funding agency. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
43. Sex differences in factors predicting post‐treatment opioid use.
- Author
-
Davis, Jordan P., Eddie, David, Prindle, John, Dworkin, Emily R., Christie, Nina C., Saba, Shaddy, DiGuiseppi, Graham T., Clapp, John D., and Kelly, John F.
- Subjects
SUBSTANCE abuse treatment ,THERAPEUTICS ,ATTITUDE (Psychology) ,AGE distribution ,SEX distribution ,TREATMENT effectiveness ,FORECASTING ,DESCRIPTIVE statistics ,ODDS ratio ,SECONDARY analysis - Abstract
Background and aims: Several reports have documented risk factors for opioid use following treatment discharge, yet few have assessed sex differences, and no study has assessed risk using contemporary machine learning approaches. The goal of the present paper was to inform treatments for opioid use disorder (OUD) by exploring individual factors for each sex that are most strongly associated with opioid use following treatment. Design Secondary analysis of Global Appraisal of Individual Needs (GAIN) database with follow‐ups at 3, 6 and 12 months post‐OUD treatment discharge, exploring demographic, psychological and behavioral variables that predict post‐treatment opioid use. Setting One hundred and thity‐seven treatment sites across the United States. Participants: Adolescents (26.9%), young adults (40.8%) and adults (32.3%) in treatment for OUD. The sample (n = 1,126) was 54.9% male, 66.1% white, 20% Hispanic, 9.8% multi‐race/ethnicity, 2.8% African American and 1.3% other. Measurement Primary outcome was latency to opioid use over 1 year following treatment admission. Results: For women, regularized Cox regression indicated that greater withdrawal symptoms [hazard ratio (HR) = 1.31], younger age (HR = 0.88), prior substance use disorder (SUD) treatment (HR = 1.11) and treatment resistance (HR = 1.11) presented the largest hazard for post‐treatment opioid use, while a random survival forest identified and ranked substance use problems [variable importance (VI) = 0.007], criminal justice involvement (VI = 0.006), younger age (VI = 0.005) and greater withdrawal symptoms (VI = 0.004) as the greatest risk factors. For men, Cox regression indicated greater conduct disorder symptoms (HR = 1.34), younger age (HR = 0.76) and multiple SUDs (HR = 1.27) were most strongly associated with post‐treatment opioid use, while a random survival forests ranked younger age (VI = 0.023), greater conduct disorder symptoms (VI = 0.010), having multiple substance use disorders (VI = 0.010) and criminal justice involvement (VI = 0.006) as the greatest risk factors. Conclusion: Risk factors for relapse to opioid use following opioid use disorder treatment appear to be, for women, greater substance use problems and withdrawal symptoms and, for men, younger age and histories of conduct disorder and multiple substance use disorder. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
44. Griffith Edwards, the Addiction Research Unit and research on the criminal justice system.
- Author
-
Farrell, Michael, Marsden, John, and Strang, John
- Subjects
ADDICTIONS ,CRIMINAL justice system ,SUBSTANCE abuse ,ALCOHOLISM treatment ,HIV infection risk factors ,SUBSTANCE abuse treatment ,RESEARCH ,ALCOHOLISM ,PEOPLE with alcoholism ,COMMUNITY health services ,CONTINUUM of care ,CRIMINOLOGY ,HEALTH facilities ,HOMELESS persons ,PRISONERS ,GOVERNMENT policy ,LEADERS ,RESEARCH personnel ,SOCIETIES - Abstract
Background This paper reviews the early work of Griffith Edwards and his colleagues on alcohol in the criminal justice system and outlines the direction of research in this area in the Addiction Research Unit in the 1960s and 1970s. The paper outlines the link between that work and work undertaken in the more recent past in this area. Methods The key papers of the authors are reviewed and the impact of this work on policy and practice is discussed. Conclusions There is a rich seam of work on deprived and incarcerated populations that has been under way at the Addiction Research Unit and subsequently the National Addiction Centre, Institute of Psychiatry, London. Griffith Edwards initiated this work that explores the risks and problems experienced by people moving between the health and criminal justice system, and demonstrated the need for better care and continuity across this system [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
45. Innovations in the Assessment and Treatment of Families with Parental Substance Misuse: Implications for Child Protection.
- Author
-
Dawe, Sharon and McMahon, Thomas J.
- Subjects
SUBSTANCE abuse treatment ,FAMILY assessment ,FAMILY psychotherapy ,PARENTS ,SERIAL publications - Abstract
An introduction is presented in which editor discusses various articles within the issue on topics including fatherhood, substance use and treatment support, importance of addressing both interpersonal violence and hostile aggressive parenting and complexity of risk within families.
- Published
- 2018
- Full Text
- View/download PDF
46. NA success linked to support by treatment.
- Author
-
Knopf, Alison
- Subjects
MEDICAL referrals ,NARCOTICS ,SUPPORT groups ,SUBSTANCE abuse treatment ,TREATMENT programs - Abstract
A deeply researched white paper shows how mutual support groups can assist — and have assisted — people trying to deal with their drug use. The paper summarizes research on the use of these support groups and details how Narcotics Anonymous (NA) helps drug users, in much the same way Alcoholics Anonymous helps alcohol users, but there are some important distinctions. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
47. The interaction of neonatal abstinence syndrome and opioid use disorder treatment availability for women insured by medicaid.
- Author
-
Reising, Virginia A., Horne, Ashley, and Bennett, Amanda C.
- Subjects
SUBSTANCE abuse treatment ,NARCOTICS ,NEONATAL abstinence syndrome ,SUBSTANCE abuse ,HEALTH services accessibility ,ACQUISITION of data methodology ,ANALGESICS ,RURAL conditions ,POPULATION geography ,PREGNANT women ,DISEASE incidence ,DESCRIPTIVE statistics ,MEDICAL records ,MEDICAID ,DISCHARGE planning ,PREGNANCY - Abstract
Objective: This paper will discuss the process of mapping opioid use disorder (OUD) treatment resources for pregnant women and discuss the intersection between treatment resources and rates of neonatal abstinence syndrome (NAS). Design: A resource manual was developed through a systematic process with stakeholders across Illinois. Resources were mapped by county and overlaid with county rates of NAS, using hospital discharge data. Results: Across Illinois, 89 treatment resources were identified for pregnant women insured by Medicaid. Resources were concentrated in 36% of Illinois' counties. Counties with limited treatment resources generally had high rates of NAS. Sixty‐six percent of NAS cases among rural Illinois residents had no OUD treatment resources in their county. Rural counties had less access to medication‐assisted treatment (MAT), the standard of care for treatment of OUD, compared with other counties across the state. Conclusions: Efforts to increase OUD treatment options for pregnant women insured by Medicaid should concentrate on geographic areas with limited access and high need. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
48. To get programs to innovate, fix deficits first, then train.
- Author
-
Knopf, Alison
- Subjects
CORPORATE culture ,DIFFUSION of innovations ,EMPLOYEE attitudes ,MOTIVATION (Psychology) ,ORGANIZATIONAL change ,PERSONNEL management ,SUBSTANCE abuse treatment ,TREATMENT programs - Abstract
This article discusses findings of the study "A Systematic Review of the Relationship Between Staff Perceptions of Organizational Readiness to Change and the Process of Innovation Adoption in Substance Misuse Treatment Programs." Topics covered include the research papers on "organizational readiness to change" reviewed by researchers, a model for outlining the measures for organizational readiness for change, and how treatment programs can embrace innovations -- new evidence-based practices.
- Published
- 2017
- Full Text
- View/download PDF
49. From both sides: Participant and facilitator perceptions of SMART Recovery groups.
- Author
-
Kelly, Peter J., Raftery, Dayle, Deane, Frank P., Baker, Amanda L., Hunt, David, and Shakeshaft, Anthony
- Subjects
SUPPORT groups ,COGNITIVE therapy ,SUPPORT groups for substance abusers ,SUBSTANCE abuse treatment ,TREATMENT programs - Abstract
Introduction and Aims: The Self-Management and Recovery Training (SMART Recovery) program provides facilitated mutual aid for people with addictions. To date, little research has examined SMART Recovery. This paper examined participant and facilitator perceptions of the helpfulness of cognitive behaviour therapy tools in SMART Recovery groups. SMART Recovery's strengths and areas for improvement were also explored, as well as overall participant satisfaction with SMART Recovery.Design and Methods: This exploratory study was conducted as part of the first national survey of SMART Recovery in Australia. Paper surveys were posted to all registered SMART Recovery groups for participants. SMART Recovery facilitators were emailed a link to an online survey.Results: Overall, satisfaction with SMART Recovery was moderate to strong. Participants and facilitators perceived the cognitive behaviour therapy tools incorporated within SMART Recovery to be helpful. Participants and facilitators nominated the group experience and the SMART Recovery tools and strategies as helpful aspects of SMART Recovery. Participants and facilitators were concerned with improving public knowledge about SMART Recovery groups, updating the structure and content of SMART Recovery groups, and increasing training for facilitators.Discussion and Conclusions: SMART Recovery displays strengths as communicated by those who utilise its services. However, there are opportunities to continue to improve SMART Recovery. Updating the training for facilitators and increasing communication between SMART Recovery Australia's head office and its facilitators may serve to improve service delivery. Future research should focus on examining the efficacy of SMART Recovery groups on participant outcomes.[Kelly PJ, Raftery D, Deane FP, Baker AL, Hunt D, Shakeshaft A. From both sides: Participant and facilitator perceptions of SMART Recovery groups. Drug Alcohol Rev 2017;36:325-332]. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
50. Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders.
- Author
-
Tiffany, Stephen T., Friedman, Lawrence, Greenfield, Shelly F., Hasin, Deborah S., and Jackson, Ron
- Subjects
SUBSTANCE abuse treatment ,COMPULSIVE behavior ,HEALTH outcome assessment ,PSYCHOMETRICS ,QUALITY of life ,SELF-efficacy ,SOCIAL adjustment ,SOCIAL support ,TREATMENT effectiveness ,EVALUATION ,THERAPEUTICS - Abstract
ABSTRACT Across the addictions field, the primary outcome in treatment research has been reduction in drug consumption. A comprehensive view of the impact of substance use disorders on human functioning suggests that effective treatments should address the many consequences and features of addiction beyond drug use, a recommendation forwarded by multiple expert panels and review papers. Despite recurring proposals, and a compelling general rationale for moving beyond drug use as the sole standard for evaluating addiction treatment, the field has yet to adopt any core set of 'other' measures that are routinely incorporated into treatment research. Among the many reasons for the limited impact of previous proposals has been the absence of a clear set of guidelines for selecting candidate outcomes. This paper is the result of the deliberations of a panel of substance abuse treatment and research experts convened by the National Institute on Drug Abuse to discuss appropriate outcome measures for clinical trials of substance abuse treatments. This paper provides an overview of previous recommendations and outlines specific guidelines for consideration of candidate outcomes. A list of outcomes meeting those guidelines is described and illustrated in detail with two outcomes: craving and quality of life. The paper concludes with specific recommendations for moving beyond the outcome listing offered in this paper to promote the programmatic incorporation of these outcomes into treatment research. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.